Provectus Biopharmaceuticals, Inc. Stock
Stocks
PVCT
US74373P1084
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
22:37:28 02/06/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.0620 USD | -7.32% |
|
+16.65% | +10.91% |
| Market Cap | 22.65M 20.28M 18.9M 17.15M 32.34M 2.17B 32.54M 227M 88.93M 1.12B 85.09M 83.21M 3.6B | P/E 2024 |
-10.6x | P/E 2025 | -4.33x |
|---|---|---|---|---|---|
| Enterprise Value | 25.38M 22.72M 21.18M 19.21M 36.23M 2.43B 36.46M 255M 99.64M 1.25B 95.34M 93.23M 4.03B | EV / Sales 2024 |
86,451,912x | EV / Sales 2025 | 78,013,766x |
| Free-Float |
92.52% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Provectus Biopharmaceuticals, Inc.
| 1 day | -7.32% | ||
| 1 week | +16.65% | ||
| Current month | +8.58% | ||
| 1 month | +9.54% | ||
| 3 months | -8.89% | ||
| 6 months | +8.77% | ||
| Current year | +10.91% |
| 1 week | 0.05 |  | 0.07 |
| 1 month | 0.05 | | 0.07 |
| Current year | 0.04 | | 0.08 |
| 1 year | 0.04 | | 0.08 |
| 3 years | 0.04 | | 0.22 |
| 5 years | 0.03 | | 0.22 |
| 10 years | 0.01 | | 0.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Edward Pershing
CEO | Chief Executive Officer | 73 | 16/04/2024 |
Eric Wachter
CTO | Chief Tech/Sci/R&D Officer | 62 | 15/05/2012 |
Heather Raines
DFI | Director of Finance/CFO | 59 | 25/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 03/04/2017 | |
John Lacey
BRD | Director/Board Member | 78 | 27/04/2018 |
Edward Pershing
CHM | Chairman | 73 | 27/04/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/3/26 A | Exercice | Chief Executive Officer | -13,216 | 0.0031% | ||
| 9/18/26 A | Exercice | Chief Executive Officer | -13,216 | 0.0031% | ||
| 9/11/26 A | Exercice | Chief Executive Officer | -13,216 | 0.1400% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.32% | +16.65% | -15.72% | -22.40% | 22.23M | |
| +0.03% | -5.67% | +50.74% | +76.76% | 70.61B | |
| +0.66% | -9.75% | +6.97% | +52.62% | 51.01B | |
| +0.31% | -0.14% | +8.84% | +32.99% | 48.1B | |
| +0.90% | -1.46% | +32.32% | +32.69% | 42.78B | |
| +2.21% | -6.61% | +302.05% | +701.45% | 40.67B | |
| -1.15% | -3.11% | +9.47% | +98.83% | 40.3B | |
| +0.45% | -1.20% | +9.11% | +43.54% | 30.59B | |
| -5.83% | -14.34% | +37.55% | +1.02% | 28.16B | |
| -1.16% | -1.84% | -6.09% | -11.99% | 24.36B | |
| Average | -1.09% | -2.53% | +43.52% | +100.55% | 37.66B | |
| Weighted average by Cap. | -0.12% | -2.97% | +52.04% | +118.62% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.62 0.55 0.52 0.47 0.88 58.99 0.89 6.19 2.42 30.44 2.32 2.27 97.97 | 0.34 0.3 0.28 0.25 0.48 32.13 0.48 3.37 1.32 16.58 1.26 1.23 53.35 |
| Net income | -4.76M -4.26M -3.97M -3.6M -6.8M -455M -6.84M -47.76M -18.7M -235M -17.89M -17.49M -756M | -5.43M -4.86M -4.53M -4.11M -7.75M -519M -7.8M -54.46M -21.32M -268M -20.4M -19.95M -862M |
| Net Debt | 2.88M 2.58M 2.4M 2.18M 4.11M 275M 4.13M 28.86M 11.3M 142M 10.81M 10.57M 457M | 2.73M 2.44M 2.28M 2.06M 3.89M 261M 3.92M 27.35M 10.71M 135M 10.25M 10.02M 433M |
Employees
6
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/10/26 | $0.0539 | +1.89% | 6,697 |
| 09/10/26 | $0.0529 | +5.80% | 30,409 |
| 08/10/26 | $0.0500 | -5.57% | 105,005 |
| 07/10/26 | $0.0530 | -0.09% | 41,800 |
| 06/10/26 | $0.0530 | -0.28% | 33,645 |
- Stock Market
- Stocks
- PVCT Stock
Select your edition
All financial news and data tailored to specific country editions
